Induction of Ras by SAF-1/MAZ through a feed-forward loop promotes angiogenesis in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Genetics

Background:

• Ras proteins are frequently hyperactivated in breast tumors, driving cancer progression.
• Vascular endothelial growth factor (VEGF) expression in triple-negative breast cancer is partly regulated by the SAF-1 transcription factor.
• Understanding Ras regulation is crucial for developing targeted breast cancer therapies.

Purpose of the Study:

• To investigate the regulatory relationship between Ras and SAF-1 in breast epithelial cells.
• To elucidate the role of SAF-1 in Ras gene expression and its potential as a therapeutic target.

Main Methods:

• Cell transformation using oncogenic Ras.
• Inhibition of the MEK/MAPK signaling pathway.
• SAF-1 gene silencing using shRNAs.
• Quantitative mRNA analysis for H-Ras and K-Ras.
• Chromatin immunoprecipitation (ChIP) assays.

Main Results:

• Oncogenic Ras activates SAF-1 DNA-binding and transcription.
• MEK/MAPK pathway inhibition blocks Ras-mediated SAF-1 activation.
• SAF-1 silencing reduces H-Ras and K-Ras mRNA levels.
• SAF-1 directly binds to H-Ras and K-Ras promoter regions, enhancing their expression.
• A novel Ras-SAF-1 transactivating loop was identified.

Conclusions:

• Ras and SAF-1 are interconnected in a positive feedback loop influencing Ras expression in breast cancer.
• SAF-1 acts as a direct transcriptional regulator of H-Ras and K-Ras.
• This loop offers a potential explanation for Ras overexpression in breast tumors without genetic Ras mutations.